Onevi

Onevi
Automates healthcare compliance with AI-powered regulatory intelligence, alerts, and an AI assistant.
About
What does Onevi do?
OneVi offers AI Compliance Intelligence for healthcare solutions, featuring an AI assistant named Vi that provides instant answers to compliance questions and stays updated on regulatory changes. The platform automates compliance, offers proactive monitoring, and delivers tailored intelligence for various healthcare organizations, from solo providers to enterprise health systems. It helps organizations navigate complex regulations, track changes, and manage compliance risks across all 50 states.
When was Onevi founded?
Onevi was founded in 2026.
What industry does Onevi operate in?
Onevi operates in HealthTech, LegalTech, Compliance Software, Regulatory Intelligence, AI Tool, Generative AI.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
AI-powered platform for medspas to automate client retention and marketing.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.